Conceptus reports first quarter financial results.SAN CARLOS San Carlos (săn kär`lōs), residential city (1990 pop. 26,167), San Mateo co., W Calif.; inc. 1925. The chief manufactures are plastic products, hardware, and machine parts. , Calif.--(BUSINESS WIRE)--April 23, 1996--Conceptus, Inc. (Nasdaq: CPTS CPTS Certified Penetration Testing Specialist (network security) CPTS Comptroller Squadron CPTS Computer Program Test Specifications CPTS Catastrophe Personnel Tracking System CPTS Claims Procedure Training Specialist ) today announced the financial results for its first quarter of fiscal year 1996, the three-month period ended March 31, 1996. The Company reported net loss of $1,465,000, or a $0.19 supplemental loss per share, on revenues of $82,000. As of March 31, 1996, the Company had cash, cash equivalents, and short-term investments of $47.9 million. In February 1996, the Company completed an initial public offering of 3.45 million shares of Common Stock, at $14.00 per share, which resulted in net proceeds Net Proceeds The amount received after all costs are deducted from the sale of a piece of property or security. Notes: In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions). of the offering to the Company of approximately $44 million. The Company's underwriters UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Securities Inc. and Piper Jaffray Piper Jaffray & Co. (NYSE: PJC), often shortened to just Piper Jaffray or PiperJaffray, is a U.S. middle-market investment banking firm based in Minneapolis, Minnesota and is a focused on delivering financial advice, investment products and transaction execution Inc., have decided to release early a portion of the shares that were subject to a 180 day lock-up in conjunction with the initial public offering. As of May 1, 1996, one-third of all common shares of Conceptus conceptus /con·cep·tus/ (-tus) the product of the union of oocyte and spermatozoon at any stage of development from fertilization until birth, including extraembryonic membranes as well as the embryo or fetus. , Inc. which were subject to the "lock-up" will be released from that lock-up provision. This will result in approximately 1.3 million shares of stock which will become immediately tradable in the public market. Some of these shares will be subject to certain restrictions upon resale. Conceptus, Inc. designs, develops and markets innovative medical devices that provide minimally invasive access to the female reproductive system reproductive system, in animals, the anatomical organs concerned with production of offspring. In humans and other mammals the female reproductive system produces the female reproductive cells (the eggs, or ova) and contains an organ in which development of the fetus . The Company's initial focus is on the development of systems to improve the diagnosis and treatment of fallopian tube fallopian tube (fəlō`pēən), either of a pair of tubes extending from the uterus to the paired ovaries in the human female, also called oviducts, technically known as the uterine tube. diseases and disorders, a primary cause of infertility. The Company is also developing a system to provide a non-surgical approach to fallopian tube sterilization sterilization Any surgical procedure intended to end fertility permanently (see contraception). Such operations remove or interrupt the anatomical pathways through which the cells involved in fertilization travel (see reproductive system). , the most commonly performed contraceptive procedure worldwide. -0-
CONCEPTUS, INC.
STATEMENTS OF OPERATIONS
(In thousands of dollars, except per share data)
(unaudited)
For the quarter ended
March 31
1996 1995
Total revenue $ 82 $ 99 Gross margin (77) (193) Operating expense 1,780 1,060 Other income, net 392 45 Net loss $(1,465) $(1,208) Supplemental loss per share(a) $ (0.19) $ (0.33) Supplemental weighted average common shares outstanding(a) 7,638 3,678 Condensed Balance Sheet
3/31/96 3/31/95
Cash, cash equivalents and short-term investments $ 47,947 $ 4,028 Total assets $ 48,765 $ 4,996 Total liabilities $ 1,398 $ 843 Redeemable convertible preferred stock $ -- $11,453 Stockholders' equity (net capital deficiency) $ 47,367 $(7,302)
(a) All shares and per share data reflect a one-for-three reverse
stock split of the Company's common and preferred stock effected on
November 29, 1995.
CONTACT: Sanford Fitch Chief Financial Officer Conceptus, Inc. (415) 802-7240 |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion